This virtual conference was jointly organised by GARDP and the BSAC. For 2022, we collaborated with the Center For Disease Dynamics, Economics & Policy (CDDEP) and the Indian Council of Medical Research (ICMR).
This conference is RCPath CPD accredited.
Programme
Select to see different time zones. Default is GMT.
SESSION ONE: KEYNOTE PRESENTATION
1030
1130
1600
View session one. This video consists of the following presentations:
1030
1130
1600
Introductory remarks
Professor Laura JV Piddock, Scientific Director, GARDP - View Bio
1035
1135
1605
Regulatory challenges and global access to new antibiotics
Dr Ramanan Laxminarayan, Director, CDDEP - View Bio
SESSION TWO: Early drug discovery: new targets and new chemistry
1115
1215
1645
View session two. This video consists of the following presentations:
1115
1215
1645
Dual fluorescent timer module for screening of anti-persister agents
Professor Ranjana Pathania, Professor Indian Institute of Technology Roorkee (IIT Roorkee) - View Bio
1130
1230
1700
Discovery and optimization of β-sliding clamp (DnaN) inhibitors
Professor Dr Anna Hirsch, Head of department, Drug Design and Optimization (DDOP) Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS) - View Bio
1145
1245
1715
New ways to identify novel antibacterial chemical entities - Identification of Novel Antibacterials Using Machine Learning Techniques
Mr Ed Siegwart, Director of Microbiology, Oppilotech Ltd - View Bio
1200
1300
1730
Q&A
SESSION THREE: Preclinical antimicrobial development
1220
1320
1750
View session three. This video consists of the following presentations:
1220
1320
1750
WHO Priority pathogen list and WHO preclinical pipeline analysis
Dr Valeria Gigante, Team Lead, One Health Research Priority-setting and Synergy in AMR, WHO - View Bio
1235
1335
1805
Overview of CARB-X pipeline
Dr Erin Duffy, Chief of Research & Development, CARB-X - View Bio
SESSION FOUR: Panel Discussion
1325
1425
1855
View session four. This video consists of the following presentations:
1325
1425
1855
Evidence for the use of old and new antibiotics
Panellists: Dr Susan Hopkins, Dr Priscilla Rupali, Dr Subasree Srinivasan, Prof. Dr Evelina Tacconelli
Dr Susan Hopkins (UKHSA) - View Bio
Dr Priscilla Rupali (Prof Infectious Diseases, Christian Medical College, Vellore) - View Bio
Dr Subasree Srinivasan (Medical Director, GARDP) - View Bio
Prof. Dr Evelina Tacconelli (University of Verona) - View Bio
1420
1520
1950
Day one closing remarks
Dr Christopher Longshaw, Senior Director, EU Scientific Affairs, Shionogi BV & BSAC Honorary Treasurer - View Bio
SESSION FIVE: Clinical development
1030
1130
1600
View session five. This video consists of the following presentations:
1030
1130
1600
Introductory remarks
Dr Christopher Longshaw, EU Scientific Advisor, Shionogi & BSAC Honorary Treasurer - View Bio
1035
1135
1605
Overview of clinical pipeline for antimicrobials - will it meet the future unmet need?
Professor Mical Paul, Head, Division of Infectious Diseases, Rambam Health Care Campus, Israel - View Bio
1050
1150
1620
Emerging antibiotic market in the Indian subcontinent
Mr Anmol Aggarwal, Lead, R&D Strategy, Venus Medicine Research Centre, India - View Bio
1105
1205
1635
Clinical development of non-traditional antibiotics
Dr Balganesh Tanjore Soundararajan, President, Gangagen Biotechnologies Pvt Ltd, Bangalore, India - View Bio
1120
1220
1650
Q&A
SESSION SIX: Oral Poster Presentations
1140
1240
1710
View session six. This video consists of the following presentations:
1140
1240
1710
Evaluating the veterinarian role in one health approach at antimicrobial resistance perspectives, Jordan
Bazzi Randa, Faculty of Public Health, University of Debrecen - View Bio
1145
1245
1715
The ESKAPE pathogens mobilome
João Botelho, Postdoctoral Researcher, Max Planck Institute for Evolutionary Biology - View Bio
1150
1250
1720
Utilising health belief model to assess antimicrobial awareness of Western Australian parents: A qualitative study
Aaron Alejandro, PhD Candidate, Murdoch University Australia - View Bio
1155
1255
1725
Nanobodies as inhibitors of the SOS-response: a new class of potential suppressors of antimicrobial resistance
Filippo Vascon, PhD student, Università degli Studi di Padova - View Bio
1200
1300
1730
Phage mediated beta-lactamases and carbapenemases in multi-drug resistant Escherichia coli
Juliet Roshini Mohan Raj, Assistant Professor, Nitte University Centre for Science Education and Research - View Bio
1205
1305
1735
Q&A
SESSION SEVEN: Impact of the COVID-19 pandemic on infections and antimicrobial resistance
1225
1325
1755
View session seven. This video consists of the following presentations:
1225
1325
1755
Impact of Covid 19 on Antimicrobial stewardship
Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
1240
1340
1810
How has Indian AMR data changed post-Covid
Dr Kamini Walia, Program officer AMR Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research - View Bio
1255
1355
1825
Impact of Covid-19 on treatment of fungal infections
Dr Arunaloke Chakrabarti, President of International Society for Human and Animal Mycology (ISHAM) - View Bio
1310
1410
1840
Q&A
SESSION EIGHT: Panel Discussion
1330
1430
1900
View session eight. This video consists of the following presentations:
1330
1430
1900
More than one way to do it – R&D of new antimicrobials: incentives and models
Panellists: Dr Anand Anandkumar, Dr Jean-Pierre Paccaud, Ms Jenny Hellmann
Dr Anand Anandkumar, Co-Founder & CEO of Bugworks - View Bio
Dr Jean-Pierre Paccaud, Director, Business Development and Corporate Strategy Global Antibiotic R&D Partnership (GARDP) - View Bio
Ms Jenny Hellmann, Assistant chief of Antibiotics and Infection control unit, Public Health Agency of Sweden - View Bio
1425
1525
1955
Closing remarks
Professor Laura JV Piddock, Scientific Director, GARDP - View Bio
Abstracts
Abstract submission is now closed
Registration
If you missed the live event, you can register here to view the recorded content from this virtual conference.
If you have not already done so, you will need to create an account before you can register.
For any questions regarding registration, please contact Esme Carruthers.
For booking Terms and Conditions click here.
